echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Study of Nervous System > Scientists have discovered the genetic network that determines the morphology of astrocytes in healthy and diseased states

    Scientists have discovered the genetic network that determines the morphology of astrocytes in healthy and diseased states

    • Last Update: 2023-01-04
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Chinese summary

    Astrocytes are a type of glial cell, which is a cell that is abundant and morphologically complex
    .
    Here, the researchers report
    the molecular distribution, diversity, and morphology
    of astrocytes in the mouse central nervous system (CNS).
    They identified shared and region-specific astrocytes genes and functions and explored the cellular origins
    of their regional diversity.
    They identified a network of genes associated with astrocytes morphology, some of which unexpectedly contained Alzheimer's disease (
    AD) risk genes
    .
    CRISPR/Cas9-mediated reduction of candidate genes reduces the morphological complexity of astrocytes and leads to cognitive deficits
    .
    The
    same genes were downregulated
    in human AD with reduced astrocyte morphology, mouse models of AD, and other human brain diseases.
    Thus, they provide comprehensive molecular data on the diversity and mechanisms of astrocytes in the central nervous system, as well as the molecular basis
    of astrocytes morphology in health and disease.

    Summary in English

    Astrocytes, a type of glia, are abundant and morphologically complex cells.
    Here, we report astrocyte molecular profiles, persity, and morphology across the mouse central nervous system (CNS).
    We identified shared and region-specific astrocytic genes and functions and explored the cellular origins of their regional persity.
    We identified gene networks correlated with astrocyte morphology, several of which unexpectedly contained Alzheimer's disease (AD) risk genes.
    CRISPR/Cas9-mediated reduction of candidate genes reduced astrocyte morphological complexity and resulted in cognitive deficits.
    The same genes were down-regulated in human AD, in an AD mouse model that displayed reduced astrocyte morphology, and in other human brain disorders.
    We thus provide comprehensive molecular data on astrocyte persity and mechanisms across the CNS and on the molecular basis of astrocyte morphology in health and disease.

    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.